In RCC, the use of a single EpCAM antibody has limited enrichment capacity for CTCs; therefore, carbonic anhydrase IX, XII (CAIX, CAXII), and cytokeratin antibodies were used to capture CTCs in conjunction with EpCAM antibodies [24, 25]. This evidence concerns the gene EPCAM and renal cell carcinoma.